iBio (IBIO) announced that iBio’s common stock has been approved for listing on Nasdaq and iBio will transfer its stock exchange listing to Nasdaq from the NYSE American.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IBIO:
- iBio Announces Transfer to Nasdaq Capital Market
- Ibio Inc Faces Financial Risk from Potential Stockholder Equity Dilution and Capital Raising Challenges
- iBio files to sell 246K shares of common stock for holders
- Biotech Alert: Searches spiking for these stocks today
- Closing Bell Movers: KB Home jumps 7% after Q4 earnings beat